Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bettina Hoeppner, Ph.D.

Co-Author

Back to Details
This page shows the publications co-authored by Bettina Hoeppner and David Mischoulon.
Bettina Hoeppner
Connection Strength
0.250
David Mischoulon
  1. Use of Staging Models for Treatment-Resistant Depression Is Not Helpful in Predicting Nonresponse to Acute Intravenous Ketamine Treatment. J Clin Psychopharmacol. 2022 Mar-Apr 01; 42(2):140-145.
    View in: PubMed
    Score: 0.062
  2. Effectiveness of Mindful Self-Compassion Training Supported by Online Peer Groups in China: A Pilot Study. Altern Ther Health Med. 2021 Sep 24.
    View in: PubMed
    Score: 0.060
  3. Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD). Brain Stimul. 2018 Jan - Feb; 11(1):75-84.
    View in: PubMed
    Score: 0.045
  4. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016 10; 21(10):1483-4.
    View in: PubMed
    Score: 0.042
  5. A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients. Mol Psychiatry. 2016 10; 21(10):1372-80.
    View in: PubMed
    Score: 0.040
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.